Cargando…
Treating diabetic complications; from large randomized clinical trials to precision medicine
In the last decades, many large randomized controlled trials have been conducted to assess the efficacy and safety of new interventions for the treatment of diabetic kidney disease (DKD). Unfortunately, these trials failed to demonstrate additional kidney or cardiovascular protection. One of the exp...
Autores principales: | Heerspink, Hiddo J. L., de Zeeuw, Dick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221145/ https://www.ncbi.nlm.nih.gov/pubmed/30294952 http://dx.doi.org/10.1111/dom.13418 |
Ejemplares similares
-
New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018) -
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations
por: Mol, Peter G. M., et al.
Publicado: (2018) -
Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives
por: de Vries, Jeroen K., et al.
Publicado: (2018) -
4429 Powering precision medicine research with the efficient construction of large diverse cohorts
por: Petukhova, Lynn, et al.
Publicado: (2020) -
The large spectrum of renal disease in diabetic patients
por: Bermejo, Sheila, et al.
Publicado: (2017)